SLC29A1 and acute myeloid leukemia: The downregulation of SLC29A1/hENT1 ara-C transporter and upregulation of cytidine-deaminase (that inactivates ara-C to an inactive metabolite) were detected in ara-C-resistant AML cells [65,66].